RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
Clinical trial NCT01252251 · COMPLETED
Trial details
- NCT number
- NCT01252251
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2016-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.